Alcon Inc. Company Profile
NYSE: ALCHealth CareOphthalmic GoodsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Alcon at a glance
Alcon Inc. (NYSE: ALC) is a Ophthalmic Goods company in the Health Care sector headquartered in Geneva, TX, Switzerland. Alcon is led by Mr. David J. Endicott and employs about 25,000 people. The company's shares have traded publicly since 2019.
At a market capitalization of $30.52 billion, it is considered a large-cap company. Its SEC Central Index Key (CIK) is 0001167379, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Alcon do?
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Business description based on the company's public filings.
Company information
- Legal name
- Alcon Inc.
- Ticker
- NYSE: ALC
- Sector
- Health Care
- Industry
- Ophthalmic Goods
- CEO
- Mr. David J. Endicott
- Employees
- 25,000
- Headquarters
- Chemin de Blandonnet 8, Geneva, TX, Switzerland
- Phone
- 41 589 112 110
- Website
- alcon.com
- IPO year
- 2019
- Market cap
- $30.52B
- SEC CIK
- 0001167379
Companies similar to Alcon
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| COOThe Cooper Companies Inc. | 54.30 | -0.82% | $10.33B | vs ALC |
| BLCOBausch + Lomb Corporation | 17.15 | -1.10% | $6.13B | vs ALC |
| WRBYWarby Parker Inc. Class A | 24.95 | -1.42% | $3.08B | vs ALC |
| EYENational Vision Holdings Inc. | 16.74 | -0.48% | $1.32B | vs ALC |
| STAASTAAR Surgical Company | 22.38 | +0.09% | $1.12B | vs ALC |
| RXSTRxSight Inc. | 4.85 | +1.04% | $201.73M | vs ALC |